Objective: A simple, accurate and economical method has been developed by Reverse Phase High Performance Liquid Chromatography (RP-HPLC) using indirect UV (Ultra Violet) method. The Principle behind the indirect UV method was applied; the copper sulfate pentahydrate with UV absorption in the mobile phase was replaced with calcium ions without UV absorption, resulting in a reduction in UV absorption of the mobile phase. Materials and Methods: Method development was carried out on strong cation exchanger column (Zorbax 300-SCX, 4.6 mm i.d. x 150 mm, particle size 5 μm). The mobile phase consists of 4 mM copper sulfate pentahydrate solution at a flow rate of 2.0 mL per min. Indirect UV detection was performed at 230.0 nm. Results: Retention time for calcium was found about 7.1 min. The developed method was validated in terms of specificity, linearity, accuracy, precision, range, limit of detection, limit of quantification and robustness. Calibration plot was linear over the concentration range of 19 to 1125 μg/mL. System suitability parameters were found 0.8 % RSD, tailing factor 1.1 and more than 8000 theoretical plates. Limit of detection and limit of quantification were found 6.3 μg/mL and 19.0 μg/mL respectively. Conclusion: The high recovery and low relative standard deviation confirm the suitability of the method for determination of calcium acetate in calcium acetate capsules.
INTRODUCTION
Calcium acetate (Figure 1 ) is a calcium salt of acetic acid. Its standard name is calcium acetate and calcium ethanolate is the systematic name. Its anhydrous form is hygroscopic in nature.
1 Calcium acetate is used to prevent high blood phosphate levels (called hyperphosphatemia) in patients who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from the blood, but it is difficult to remove enough to keep the phosphate levels balanced. Decreasing blood phosphate levels can help keep the bones strong, prevent unsafe buildup of minerals in the body and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Calcium acetate is a natural mineral that works by holding onto phosphate from the diet so that it can pass out of the body. 2 Chromophore is covalently unsaturated group which is responsible for electronic absorption. The color usually appears in an organic compound if it contains certain unsaturated groups. These unsaturated groups are called chromophores and any compounds having this chromophore are called chromogen. 3 Those compounds which are not having chromophore are very difficult to analyze by RP-HPLC using UV detector and can be analyzed by external derivatization, in situ derivatization or indirect UV methods.
Calcium acetate structure does not have any chromophore, hence it does not shows any absorbance in UV-Visible range. The literature survey revealed that calcium acetate assay in active pharmaceutical ingredient and tablets has been reported by titrimetry in United State Pharmacopoeia. 4 The atomic absorption spectroscopy method has been reported in United States Pharmacopoeia for dissolution of calcium acetate tablets. 5 European pharmacopoeia also reported assay of calcium acetate by complexometric titration of calcium. 6 Few methods are reported for determination of calcium in serum by atomic absorption spectroscopy. 7, 8 Calcium determination by flame photometry is also reported. 9, 10 Some methods are reported estimation of calcium by Inductively coupled plasma-mass spectroscopy (ICP-MS). 11, 12 It was observed that there is no method available for quantitative estimation of calcium acetate in calcium acetate capsules by RP-HPLC using UV detector, hence the present work was undertaken to develop and validate a simple, accurate and economical method by RP-HPLC using UV detector which can be used for routine analysis in quality control and research laboratory for assay of calcium acetate in capsules.
MATERIA LS
Copper sulfate pentahydrate (ACS grade, EC No. 231-847-6) was procured from Merck Millipore, India. Calcium acetate working standard (secondary standard traceable to USP) was procured from Sigma-Aldrich (Catalog No. PHR1362). HPLC grade water was used from Milli-Q water purifier system. The marketed calcium acetate capsule formulation (Calcium Acetate Gelcaps 667mg, Make: Fresenius Medical Care, North America) was used for analysis of drug product.
METHODS
The method was developed and validated on Agilent's 1260 Infinity II series automated HPLC system with UV detector using EZChrome Elite software, version 3.3.2 SP2. The method used to estimate calcium is indirect UV method. 13 The chromatographic parameters were optimized and optimized chromatographic conditions are shown in Table 1 .
Mobile phase (4 mM Copper sulfate pentahydrate solution)
Dissolved 1000 mg of copper sulfate pentahydrate in 1000 mL of HPLC grade water and filtered through 0.45µm, nylon 6,6 membrane filter and degassed under sonication for 10 min.
Diluent and blank
Used HPLC grade water as diluent and blank.
Standard preparation (about 750 µg/mL)
Weighed accurately and transferred 75.0 mg of calcium acetate working standard in to a 100 mL volumetric flask. Added 70 mL of diluent, sonicated to dissolve and made volume up to mark with diluent. Filtered the solution through 0.45 µm Polyvinylidene Fluoride (PVDF) syringe filter by discarding about first 3 mL of filtrate.
Check standard preparation (about 750 µg/mL)
Weighed accurately and transferred 75 mg of calcium acetate working standard in to a 100 mL volumetric flask. Added 70 mL of diluent, sonicated to dissolve and made volume up to mark with diluent. Filtered the solution through 0.45 µm Polyvinylidene Fluoride (PVDF) syringe filter by discarding about first 3 mL of filtrate.
Test sample preparation (about 750 µg/mL)
Crushed 20 capsules content in fine powder. Weighed accurately and transferred capsule powder equivalent to 150 mg of calcium acetate in to a 200 mL volumetric flask. Added 170 mL of diluent, sonicated for 20 min with intermittent shaking and made volume up to mark with diluent. Filtered the solution through 0.45 µm Polyvinylidene Fluoride (PVDF) syringe filter by discarding about first 3 mL of filtrate.
Method validation
The developed method was validated as per International Conference on Harmonization (ICH) Q2 (R1) 14 guidelines and United States Pharmacopoeia general chapter <1225>. 15 
System suitability
System suitability was checked in accordance with United States Pharmacopoeia general chapter <621>. 16 % relative standard deviation for six replicate standard, similarity factor for check standard, tailing factor and theoretical plate count of calcium peak were evaluated.
Specificity
The developed method was validated for specificity by injecting blank and placebo solution in triplicate. The chromatograms were evaluated for any interference at the retention time of calcium peak.
Precision
Precision of the development method was evaluated by injecting six test sample preparations from a homogenous fine capsule powder. % assay and % relative standard deviation of six test samples were calculated for calcium acetate. Intermediate precision of the method was also evaluated using different analyst, different HPLC system and different column by injecting six test sample prepared as same for precision. The acceptance criteria for individual precision % RSD was not more than 2.0 and for 12 assay results was not more than 3.0. The mean assay difference of individual precision was not more than 2.0%.
Accuracy (Recovery)
Recovery study was performed to evaluate the accuracy of the method by spiking method. Recovery study was done by spiking calcium acetate standard in to placebo in the concentration of 50%, 100% and 150% level of the proposed concentration. The test samples were prepared in triplicate at each level and injected in the proposed chromatographic conditions. % recovery of calcium acetate was calculated for all the levels. The acceptance criterion for recovery of calcium acetate was 98.0 to 102.0% and % RSD for nine recovery results was not more than 2.0.
Limit of Detection (LOD) and Limit of Quantitation (LOQ)
LOD and LOQ were determined by standard deviation of the response and slope method. The linearity was performed from 5 to 100% of the proposed concentration by diluting standard solution. LOD and LOQ were determined by using following formulae: LOD = 3.3×(σ/S) LOQ = 10×(σ/S) Where σ = standard deviation of response and S = slope determined from calibration curve of linear plot.
Linearity
Linearity of the method was established for calcium acetate from LOQ to 150% of the proposed concentration using nine calibration levels (LOQ, 5, 10, 25, 50, 75, 100, 125 and 150%) from the range LOQ to 1125 µg/ mL. The working standard was used to prepare calibration levels. The calibration curve was plotted for each level as concentration of level verses peak response. The result of linearity was evaluated by regression analysis.
Robustness
For robustness study, three chromatographic parameters were considered such as (i) concentration of mobile phase ±10% (3.6 and 4.4 mM copper sulfate pentahydrate solution), (ii) flow rate ±10% (1.8 and 2.2 mL/ min) and (iii) column temperature ±5°C (20°C and 30°C). Robustness of the method was evaluated by system suitability and assay of formulation.
Solution stability
Solution stability was established for standard and test sample preparations. Bench-top (ambient temperature) stability was established by injecting standard and test sample at regular interval for seven days. Solution stability was established by calculating similarity factor for standard against fresh standard and % assay difference for test sample from initial assay.
RESULTS AND DISCUSSION

Method development
The Principle behind the indirect UV method was applied; the copper sulfate pentahydrate with UV absorption in the mobile phase was replaced with calcium ions without UV absorption, resulting in a reduction in UV absorption of the mobile phase. 13 Several trials were taken to optimize the concentration of copper sulfate pentahydrate, flow rate and injection volume to achieve good peak shape and better retention of calcium peak. It was observed that the concentration of copper sulfate pentahydrate is indirectly proportional to retention of calcium peak. The most optimized chromatographic conditions are summarized in Table 1 .
System suitability
System suitability of the method was evaluated by means of % relative standard deviation for six replicate standard, similarity factor for check standard, tailing factor and theoretical plate count of calcium peak and found within the acceptance criteria. The results are presented in Table 2 .
Specificity
The specificity was performed to check blank and placebo interference. The chromatograms show (Figures  2-5 ) no interference at the retention time of calcium peak due to blank and placebo.
Precision
Precision of the method was evaluated by injecting six test sample preparations from a homogenous fine capsule powder and % RSD of assay (n=6) was found to be 0.6, whereas for intermediate precision it was found to be 0.5. % RSD of precision and intermediate precision (n=12) was found to be 0.6. The mean % assay difference was found to be 0.4 between precision and intermediate precision.
The results were found within acceptance criteria for precision of the developed method. The results of precision are compiled in Table 3 .
Accuracy (Recovery)
The accuracy was evaluated by calculating the recoveries at 50%, 100% and 150% level of the proposed concentration and the mean % recoveries (n=3) were found to be 98.0, 99.0 and 100.0 respectively. The mean % recov- ery of all levels (n=9) was found to be 100.0 with 0.5 % RSD. The recoveries were found within the acceptance criteria and method found to be accurate. The results of accuracy are presented in Table 4 .
LOD and LOQ
LOD and LOQ were determined by standard deviation of the response and slope method. The LOD and LOQ of the method were found to be 6.3 µg/mL and 19.0 µg/mL respectively.
Linearity
The developed method was found to be linear from LOQ to 150% of the proposed concentration over ) was found to be 1.000. Linearity graph of calcium acetate is shown in Figure 6 . Chromatograms at LOQ and 150 % are shown in Figure 7 -8.
Robustness
The robustness of method was evaluated by changing critical chromatographic parameters like concentration of mobile phase, flow rate and column temperature. Robustness results were found within the acceptance criteria and presented in Table 5 .
Solution stability
Solution stability of calcium acetate standard and test sample solution was established and found to be stable for seven days on bench-top (ambient temperature). Similarity factor for standard after seven days was found to be 0.99 and % assay difference for test sample from initial assay was found to be 0.3. 
CONCLUSION
The developed method was validated as per ICH and USP guidelines for specificity, precision, accuracy, linearity and robustness over the range of 325 to 1125 µg/ mL and found meeting the acceptance criteria for all parameters. The proposed method is innovative, simple, accurate, robust and economical method for quantitative estimation (assay) of calcium acetate in calcium acetate capsules by RP-HPLC using UV detector can be used for routine analysis in quality control and research laboratory as an economical and easy alternative to the more sophisticated and expensive to run instruments.
